Skip to content
GLP-1 Desk
Menu
Dispatch #28

REMEVi

A flat rate at every dose — $219 semaglutide, $319 tirzepatide — verified, across all 50 states and DC.

Visit REMEVi ↗Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$219/mo
Tirzepatide
$319/mo
Coverage
All 50 states
Brand-name
Compounded only

Weigh REMEVi against the full ranked field on the best semaglutide providers ranking, or line it up against its closest alternatives. Or go one-on-one: REMEVi vs CoreAge Rx. Because REMEVi dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency84/100
State access96/100
Molecule range82/100
Onboarding speed82/100
Support responsiveness82/100
Licensing & trust88/100

What the Desk likes

  • A genuinely flat rate: the same price at every dose, with no upcharge as you titrate
  • LegitScript-verified operator, all 50 states and DC
  • A daily oral semaglutide tablet alongside the injection
  • Longer terms published openly rather than used as a teaser — $189 on 12 weeks, $149 on 52

Where points come off

  • The flat rate is a higher entry price than teaser-led competitors
  • No brand-name access

The Desk's briefing — B

Best for: Patients who want one price that does not rise as the dose does, with nationwide reach.

REMEVi ranks #28 of 508 providers scored — see #1, CoreAge Rx here.

Visit REMEVi ↗

Related dispatches

Everyone else here (24)

Pricing and verification reflect REMEVi's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.

← Back to The Desk